Changes in PESI scores predict mortality in intermediate-risk patients with acute pulmonary embolism

European Respiratory Journal

Volumn 41, Issue 2, 2013, Pages 354-359

  Moores, Lisa ^a   Zamarro, Celia ^c   Gomez, Vicente ^c   Aujesky, Drahomir ^d   Garcia, Leticia ^c   Nieto, Rosa ^c   Yusen, Roger ^b   Jiménez, David ^c  

^a Uniformed Services University of the Health Sciences   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Mortality; Prognosis; Pulmonary embolism; Pulmonary embolism severity index; Reclassification

Indexed keywords

ACENOCOUMAROL; ANTIVITAMIN K; ENOXAPARIN; FIBRINOLYTIC AGENT; HEPARIN;

ACUTE DISEASE; AGED; ARTICLE; COHORT ANALYSIS; DEATH; FEMALE; HIGH RISK PATIENT; HUMAN; LOW RISK POPULATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RISK; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PULMONARY EMBOLISM SEVERITY INDEX; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VENA CAVA FILTER;

AGED; AMBULATORY CARE; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; PULMONARY MEDICINE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84873404416     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00225011     Document Type: Article

References (21)

1. Heit JA. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombol 2006; 21: 23-29.
2. Tapson VF. Acute pulmonary embolism. New Engl J Med 2008; 358: 1037-1052.
3. Othieno R, Abu Affan M, Okpo E. Home versus in-patient treatment for deep vein thrombosis. Cochrane Database Syst Rev 2007; 3: CD003076.
4. Zidane M, van Hulsteijn LH, Brenninkmeijer BJ, et al. Out of hospital treatment with subcutaneous low molecular weight heparin in patients with acute deep-vein thrombosis: A prospective study in daily practice. Haematologica 2006; 91: 1052-1058.
5. Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172: 1041-1046.
6. Jiménez D, Aujesky D, Moores L, et al. Simplification of the Pulmonary Embolism Severity Index for prognosticating patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010; 170: 1383-1389.
7. Jimenez D, Yusen RD, Otero R, et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest 2007; 132: 24-30.
8. Aujesky D, Roy PM, Le Manach CP, et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J 2006; 27: 476-481.
9. Conget F, Otero R, Jiménez D, et al. Short-term clinical outcome after acute symptomatic pulmonary embolism. Thromb Haemost 2008; 100: 937-942.
10. PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of the pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263: 2753-2759.
11. Turkstra F, Kuijer PM, van Beek EJ, et al. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med 1997; 126: 775-781.
12. Remy-Jardin M, Remy J, Wattinne L, et al. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breath-hold-technique-comparison with pulmonary angiography. Radiology 1992; 185: 381-387.
13. Prandoni P, Cogo A, Bernardi E, et al.A simple approach for detection of recurrent proximal vein thrombosis. Circulation 1993; 88: 1730-1735.
14. PencinaMJ,D'Agostino RB Sr., D'Agostino RB Jr., et al. Evaluating the added predictive ability from a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172.
15. Aujesky D, Perrier A, Roy PM, et al. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med 2007; 261: 597-604.
16. Aujesky D, Roy PM, Verschuren F, et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: An international, open-label, randomised, non-inferiority trial. Lancet 2011; 378: 41-48.
17. Jiménez D, Yusen RD. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Curr Opin Pulm Med 2008; 14: 414-421.
18. Jiménez D, Aujesky D, Díaz, et al. Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med 2010; 181: 983-991.
19. Scridon T, Scridon C, Skali H, et al. Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism. Am J Cardiol 2005; 96: 303-305.
20. Jiménez D, Aujesky D, Moores L, et al. Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism. Thorax 2011; 66: 75-81.
21. Konstantinides S, Geibel A, Heusel G, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347: 1143-1150.